Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Herrera

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
ACS Synthetic Biology|September 2, 2025
APEX: Automated Protein EXpression in <i>Escherichia coli</i>Martyna Kasprzyk, Michael A Herrera, Giovanni Stracquadanio
Nature Communications|December 1, 2024
Protein engineering using variational free energy approximationEvgenii Lobzaev, Michael A Herrera, Martyna Kasprzyk, et al.
ACS Catalysis|October 31, 2022
Coupled Natural Fusion Enzymes in a Novel Biocatalytic Cascade Convert Fatty Acids to AminesShona M Richardson, Piera M Marchetti, Michael A Herrera, et al.
Chembiochem : a European Journal of Chemical Biology|June 13, 2022
BioWF: A Naturally-Fused, Di-Domain Biocatalyst from Biotin Biosynthesis Displays an Unexpectedly Broad Substrate ScopeShona M Richardson, Peter J Harrison, Michael A Herrera, et al.
ACS Catalysis|November 21, 2024
Repurposing a Fully Reducing Polyketide Synthase toward 2-Methyl Guerbet-like LipidsMichael A Herrera, Stephen McColm, Louise-Marie Craigie, et al.
RSC Chemical Biology|May 13, 2026
<i>De novo</i> acyl carrier proteins display structure-independent modification and sequence noveltyMichael A Herrera, Grace K King, Zoe Ozols, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
<i>De novo</i> acyl carrier proteins display structure-independent modification and sequence noveltyMichael A Herrera, Grace K King, Zoe Ozols, et al.
Cardiorenal Medicine|December 27, 2023
Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative StudyJennifer Arney, L Parker Gregg, Sheena Wydermyer, et al.
American Journal of Nephrology|May 26, 2023
Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney DiseaseL Parker Gregg, Peter A Richardson, Michael A Herrera, et al.
Faraday Discussions|June 10, 2024
Developing deprotectase biocatalysts for synthesisLisa Kennedy, Mariyah Sajjad, Michael A Herrera, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
ACS Synthetic Biology|September 2, 2025
APEX: Automated Protein EXpression in <i>Escherichia coli</i>Martyna Kasprzyk, Michael A Herrera, Giovanni Stracquadanio
Nature Communications|December 1, 2024
Protein engineering using variational free energy approximationEvgenii Lobzaev, Michael A Herrera, Martyna Kasprzyk, et al.
ACS Catalysis|October 31, 2022
Coupled Natural Fusion Enzymes in a Novel Biocatalytic Cascade Convert Fatty Acids to AminesShona M Richardson, Piera M Marchetti, Michael A Herrera, et al.
Chembiochem : a European Journal of Chemical Biology|June 13, 2022
BioWF: A Naturally-Fused, Di-Domain Biocatalyst from Biotin Biosynthesis Displays an Unexpectedly Broad Substrate ScopeShona M Richardson, Peter J Harrison, Michael A Herrera, et al.
ACS Catalysis|November 21, 2024
Repurposing a Fully Reducing Polyketide Synthase toward 2-Methyl Guerbet-like LipidsMichael A Herrera, Stephen McColm, Louise-Marie Craigie, et al.
RSC Chemical Biology|May 13, 2026
<i>De novo</i> acyl carrier proteins display structure-independent modification and sequence noveltyMichael A Herrera, Grace K King, Zoe Ozols, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
<i>De novo</i> acyl carrier proteins display structure-independent modification and sequence noveltyMichael A Herrera, Grace K King, Zoe Ozols, et al.
Cardiorenal Medicine|December 27, 2023
Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative StudyJennifer Arney, L Parker Gregg, Sheena Wydermyer, et al.
American Journal of Nephrology|May 26, 2023
Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney DiseaseL Parker Gregg, Peter A Richardson, Michael A Herrera, et al.
Faraday Discussions|June 10, 2024
Developing deprotectase biocatalysts for synthesisLisa Kennedy, Mariyah Sajjad, Michael A Herrera, et al.
Pageof 2